NOTES: 

i. The list of projects in this report includes all projects  approved by AIIB that began disbursement before  December 31, 2022. Projects approved but were not  disbursed in 2022 are not included. 

ii. Target results refer to expected result indicators at the  time of project approval. For sovereign projects, result  indicators can be found in Annex 1 Results Monitoring  Framework of each Project Document available on  AIIB’s website. For nonsovereign projects, objectives  and expected results can be found in each Project  Summary available on AIIB’s website. 

iii. AIIB commitment amount refers to net commitment  amount, which equals signed amount minus cumulative  cancellation. Non-USD currencies are converted to  USD using the spot exchange rate on Dec. 31, 2022.

iv. Unless otherwise specified, AIIB share shows the share  of the financing amount approved by AIIB in the total  project cost at the time of project approval and may not  reflect the latest updates. When a project is cofinanced,  the share could be used to apportion total results to  AIIB. Where the amount appears with an *, it means the  amount has been updated with the actual total project  cost.

v. Cumulative disbursement amounts are as of  December 31, 2022 and may not reflect the latest  updates. Non-USD currencies are converted to USD  using the spot exchange rate on December 31, 2022. 

Cumulative disbursement amounts are not disclosed  for some nonsovereign projects due to confidentiality  considerations.